The Irving Institute is currently accepting applications for TL1 Training Program, for Doctoral Students and Postdoctoral Appointees For Immediate Start and 2018-2019

funding education mentorship mentorship mentorship

The TRx Pilot Award pre-proposal deadline has now passed. The first session of the TRx Drug Development Boot Camp will begin on Monday January 29, 2017. The boot camp is open to all Columbia faculty, students, and staff.


TRx Drug Development Boot Camp

The Translational Therapeutics (TRx) Drug Development Boot Camp is a 5-part series designed to provide academic investigators with an overview of key aspects of the drug development pathway. This series is open to all Columbia faculty, students, and staff.

Time: Mondays, 4:00p-6:00p
Location: 622 West 168th St, New York, NY , PH 10-405

2018 TRx Boot Camp Schedule




Session I
January 29

“Kick Off Session & Drug Development”
*TRx Applicants &Steering Committee only*

Bruce Conway, PhD
Program Director, Robertson Therapeutic Fund at Rockefeller University

Session II
February 5

“Who is my Target Customer” Unmet clinical need, competitive landscape and stakeholder discovery

Harvey Homan, PhD, MBA
HDH Associates International
Jumpstart NJ Angel Network

Session III
February 12

“What Does My Target Product Look Like” Target Product Profile development

Randall Kaye, MD
Global Head of Medical Affairs, SSI Strategy

Session VI
February 20 (TUESDAY)
Joint with BiomedX

“How do I Protect My Innovation” Patenting and licensing discussion with Columbia’s licensing office

Jeffrey Sears, PhD, JD
Office of General Counsel
Ron Katz, PhD, MBA
Columbia Technology Ventures

Session IV
February 26

“What are the right Pre-Clinical Studies and What Resources are available at Columbia?” A review of IND enabling studies and Columbia’s core facilitates

Stephanie Oestreich
EVP, Head BRIDGEs Partnerships NA- Evotec

Brian Walsh

Serge Cremers, PhD, PharmD
Columbia University

Session V
March 5

“How do I Approach the FDA” IND and Clinical trial design, led by Columbia’s Clinical Trials Office

Helen Kim, PharmD
Executive Director, Columbia Clinical Trials Office

Jane Cho, MS, MPH
Manager of Regulatory Science, Columbia Clinical Trials Office

Session VI
March 12

“How do I Fund My Studies” A Panel discussion with industry and NIH representatives, led by SPA.

Nader Halim, PhD
Senior Director, Pfizer CTI

Alexis Desrichard, PhD

Moderator: Rudi Odeh-Ramadan, PharmD
Vice President for Research Administration, Columbia Sponsored Projects Administration

Session VII
March 19 or 20

“How to Pitch my Innovation” Pitch crafting techniques

Joint with BiomedX

Session VIII
March 26

“Closing Session”



Time: 4-5:30p
Location: Irving Institute, PH 10-405

2017 TRx Boot Camp





Session I
January 23

Market Research & Competitive Analysis

Lorraine Marchand, MBA
Centricity Health


Session II
January 30

Intellectual Property, Licensing, and Sponsored Research

Teresa Chen, PhD, JD Columbia Office of General Counsel
Ron Katz, PhD, MBA Columbia Technology Ventures


Session III
February 6

Developing a Target Product Profile

Randall Kaye, MD
SSI Strategy


Session IV
February 13

Experimental Design with Translational Perspective

Anton Simeonov, PhD NCATS,NIH


Session V
February 27

Working with the FDA

Dilcia Granville, PhD